SCHEMBL5485625

SCHEMBL5485625

CS(=O)(=O)n1cnc2cnccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 1/20 0.46
ALDH3A1 P30838 3/20 0.39
HTT P42858 3/20 0.39
POLB P06746 1/20 0.39
NOD1 Q9Y239 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HTR6 P50406 2/20 0.38
CHEK1 O14757 1/20 0.36
ATR Q13535 1/20 0.36
PDCD1 Q15116 1/20 0.36
ATRIP Q8WXE1 1/20 0.36
CD274 Q9NZQ7 1/20 0.36
TSHR P16473 1/20 0.35
RAPGEF4 Q8WZA2 1/20 0.35
HSD17B10 Q99714 1/20 0.35
LTA4H P09960 1/20 0.35
PTGS2 P35354 1/20 0.35
JAK2 O60674 1/20 0.34
JAK3 P52333 1/20 0.34
ATM Q13315 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24668966 0.86 ALDH3A1 (0.39) FGFR1ALDH3A1HTTPOLBNOD1
SCHEMBL5031362 0.83 FGFR1 (0.46) FGFR1ALDH3A1HTTPOLBNOD1
SCHEMBL7100805 0.77 ALDH3A1 (0.61) ALDH3A1HTTPOLBNOD1L3MBTL1
SCHEMBL7167915 0.73 CHRM1 (0.41) FGFR1ALDH3A1HTTPOLBNOD1
SCHEMBL19848198 0.72 HTT (0.51) FGFR1ALDH3A1HTTPOLBNOD1
SCHEMBL256337 0.72 FGFR1 (0.53) FGFR1TSHRHSD17B10LTA4HJAK2
SCHEMBL29593970 0.72 FGFR1 (0.53) FGFR1TSHRHSD17B10LTA4HJAK2
SCHEMBL19848703 0.71 POLB (0.48) ALDH3A1HTTPOLBNOD1L3MBTL1
SCHEMBL4421419 0.70 FDPS (0.41) TSHRHSD17B10LTA4H
SCHEMBL24670231 0.70 RAPGEF4 (0.60) HTR6RAPGEF4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022187693-A1 COVALENT CDK2-BINDING COMPOUNDS FOR THERAPEUTIC PURPOSES UMBRA THERAPEUTICS INC. (US) 2022-09-09 WO disclosed
EP-2585462-A1 FUSED HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASES (PDES) INHIBITORS Takeda Pharmaceutical Company Limited (JP) 2013-05-01 EP disclosed
WO-2007047793-A2 CYCLOPENTENOL NUCLEOSIDE COMPOUNDS, INTERMEDIATES FOR THEIR SYNTHESIS AND METHODS OF TREATING VIRAL INFECTIONS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2007-04-26 WO disclosed